DeepMed Research

Gustave Roussy, Cancer Campus, Grand Paris

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Other: beauty care

First Posted Date: 2011-10-25

Last Posted Date: 2014-05-06

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 400

Registration Number: NCT01459003

Locations: 🇫🇷
Gustave Roussy, Villejuif, Val de Marne, France

Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer

Not Applicable

Terminated

Conditions: Thyroid Cancer
Metastases

Interventions: Drug: TSH stimulation

First Posted Date: 2011-07-27

Last Posted Date: 2016-07-13

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 4

Registration Number: NCT01403324

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma

Phase 2

Completed

Conditions: Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)

Interventions: Drug: Placebo
Drug: Sunitinib

First Posted Date: 2011-06-10

Last Posted Date: 2022-08-04

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 78

Registration Number: NCT01371201

Locations: 🇮🇹
University of Padova, Padova, Italy
🇫🇷
Institut de Cancérologie Gustave roussy, Villejuif, France
🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, GA, Netherlands

and more 1 locations

Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced Fibrosis

Phase 2

Completed

Conditions: Fibrosis

Interventions: Drug: Pravastatin

First Posted Date: 2010-12-29

Last Posted Date: 2019-06-13

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 61

Registration Number: NCT01268202

Locations: 🇫🇷
Hôpital Européen Georges Pompidou, Paris, France
🇫🇷
Institut Gustave Roussy, Villejuif, France
🇫🇷
Centre Val d'Aurelle, Montpellier, France

Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients

Phase 3

Conditions: Ovarian Metastases
Colorectal Cancer With a Resected Minimal Synchronous PC
Tumour Rupture in the Abdominal Cavity

Interventions: Procedure: laparotomy plus HIPEC

First Posted Date: 2010-10-22

Last Posted Date: 2017-01-26

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 130

Registration Number: NCT01226394

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract

Phase 2

Completed

Conditions: Squamous Cell Carcinoma

Interventions: Radiation: single-fraction radiotherapy with concomitant 5FU and Hydrea
Radiation: hyperfractionated radiotherapy with concomitant Cetuximab

First Posted Date: 2010-09-30

Last Posted Date: 2017-05-16

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 60

Registration Number: NCT01211938

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Drug: Genomic driven chemotherapy
Drug: Chemotherapy

First Posted Date: 2010-08-12

Last Posted Date: 2012-03-16

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 303

Registration Number: NCT01180335

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer

Phase 1

Conditions: Non-small Cell Lung Cancer
Locally Advanced Disease

First Posted Date: 2010-07-22

Last Posted Date: 2012-04-04

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 36

Registration Number: NCT01167530

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes

Phase 2

Completed

Conditions: Non Small Cell Lung Cancer

First Posted Date: 2010-07-09

Last Posted Date: 2018-03-29

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 41

Registration Number: NCT01159288

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Procedure: MRI±biopsy

First Posted Date: 2010-04-28

Last Posted Date: 2016-01-26

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 360

Registration Number: NCT01112254

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy